ArticleQuantitative imaging in medicine and surgery2026
Native T1-rho mapping for myocardial scar detection in patients with probable or confirmed coronary artery disease.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: T1rho cardiac mapping is an emerging, non-contrast magnetic resonance imaging (MRI) technique sensitive to myocardial biochemical and microstructural changes, whereas late gadolinium enhancement (LGE) remains the reference standard for scar visualization, though its reliance on contrast agent limits its applications and raises safety and environmental concerns. This study aimed to evaluate native T1-rho (T1ρ) mapping in detecting myocardial scars, compared with the gold standard LGE method. Methods: A prospective study was conducted, including patients with suspected or known coronary artery disease (CAD). In addition to adenosine stress cardiac magnetic resonance (CMR) and LGE, native T1ρ mapping was performed. T1ρ-weighted images were acquired at the mid-left ventricular level using a spin-lock preparation pulse with varying durations (0, 20, 30, 40 ms) and a maximum amplitude of 500 Hz. Subsequently, a T1ρ map was generated and compared to LGE for visual assessment, scar quantification, and diagnostic performance. Results: Of the 250 participants, 75 (30%) were categorized as positive scar based on LGE findings. The sensitivity and specificity (with 95% confidence interval) for scar detection using T1ρ mapping alone were 39% (29-50%) and 88% (83-93%), respectively, which increased to 71% (60-80%) and 99% (96-100%), respectively, by combining with steady-state free precession (SSFP) cine. T1ρ relaxation time in the scarred area was significantly higher than the average T1ρ at the septum of the negative scar group (77.9±7.2 Conclusions: Native T1ρ mapping can serve as an alternative method to standard LGE method for detecting myocardial scar with good reproducibility and high specificity, though sensitivity was low when only using T1ρ maps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.